These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1088 related articles for article (PubMed ID: 30377031)
21. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient. Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579 [TBL] [Abstract][Full Text] [Related]
22. A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness. Pritchard MF; Powell LC; Jack AA; Powell K; Beck K; Florance H; Forton J; Rye PD; Dessen A; Hill KE; Thomas DW Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630204 [TBL] [Abstract][Full Text] [Related]
23. Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1. Riera E; Macià MD; Mena A; Mulet X; Pérez JL; Ge Y; Oliver A J Antimicrob Chemother; 2010 Jul; 65(7):1399-404. PubMed ID: 20435779 [TBL] [Abstract][Full Text] [Related]
24. Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators. Luján AM; Maciá MD; Yang L; Molin S; Oliver A; Smania AM PLoS One; 2011; 6(11):e27842. PubMed ID: 22114708 [TBL] [Abstract][Full Text] [Related]
25. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System. Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523 [TBL] [Abstract][Full Text] [Related]
26. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis]. Coban AY; Ciftci A; Onuk EE; Erturan Z; Tanriverdi Cayci Y; Durupinar B Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909 [TBL] [Abstract][Full Text] [Related]
27. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277 [TBL] [Abstract][Full Text] [Related]
28. Within-Host Evolution of the Dutch High-Prevalent Pseudomonas aeruginosa Clone ST406 during Chronic Colonization of a Patient with Cystic Fibrosis. van Mansfeld R; de Been M; Paganelli F; Yang L; Bonten M; Willems R PLoS One; 2016; 11(6):e0158106. PubMed ID: 27337151 [TBL] [Abstract][Full Text] [Related]
29. Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients. García-Castillo M; del Campo R; Baquero F; Morosini MI; Turrientes MC; Zamora J; Cantón R Clin Microbiol Infect; 2011 May; 17(5):704-11. PubMed ID: 20673272 [TBL] [Abstract][Full Text] [Related]
30. An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections. Koeva M; Gutu AD; Hebert W; Wager JD; Yonker LM; O'Toole GA; Ausubel FM; Moskowitz SM; Joseph-McCarthy D Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923873 [TBL] [Abstract][Full Text] [Related]
31. Characterization of clonal strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Ontario, Canada. Beaudoin T; Aaron SD; Giesbrecht-Lewis T; Vandemheen K; Mah TF Can J Microbiol; 2010 Jul; 56(7):548-57. PubMed ID: 20651854 [TBL] [Abstract][Full Text] [Related]
32. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study. Millar BC; Rendall JC; Downey DG; Moore JE J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786 [TBL] [Abstract][Full Text] [Related]
33. Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis. Evans TJ Future Microbiol; 2015; 10(2):231-9. PubMed ID: 25689535 [TBL] [Abstract][Full Text] [Related]
34. Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection. Darch SE; McNally A; Harrison F; Corander J; Barr HL; Paszkiewicz K; Holden S; Fogarty A; Crusz SA; Diggle SP Sci Rep; 2015 Jan; 5():7649. PubMed ID: 25578031 [TBL] [Abstract][Full Text] [Related]
35. Biofilm differentiation and dispersal in mucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Kirov SM; Webb JS; O'May CY; Reid DW; Woo JKK; Rice SA; Kjelleberg S Microbiology (Reading); 2007 Oct; 153(Pt 10):3264-3274. PubMed ID: 17906126 [TBL] [Abstract][Full Text] [Related]
36. Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants. Silva E; Monteiro R; Grainha T; Alves D; Pereira MO; Sousa AM Front Cell Infect Microbiol; 2020; 10():441. PubMed ID: 32974221 [TBL] [Abstract][Full Text] [Related]
37. Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria. Strateva T; Petrova G; Mitov I J Chemother; 2010 Dec; 22(6):378-83. PubMed ID: 21303744 [TBL] [Abstract][Full Text] [Related]
38. Alginate lyase immobilized chitosan nanoparticles of ciprofloxacin for the improved antimicrobial activity against the biofilm associated mucoid P. aeruginosa infection in cystic fibrosis. Patel KK; Tripathi M; Pandey N; Agrawal AK; Gade S; Anjum MM; Tilak R; Singh S Int J Pharm; 2019 May; 563():30-42. PubMed ID: 30926526 [TBL] [Abstract][Full Text] [Related]
39. Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis. Aaron SD; Ferris W; Ramotar K; Vandemheen K; Chan F; Saginur R J Clin Microbiol; 2002 Nov; 40(11):4172-9. PubMed ID: 12409393 [TBL] [Abstract][Full Text] [Related]
40. Phenotypic & genotypic variants of Pseudomonas aeruginosa isolated from children with cystic fibrosis in India. Agarwal G; Kapil A; Kabra SK; Chandra R; Das B; Diwedi SN Indian J Med Res; 2002 Aug; 116():73-81. PubMed ID: 12592994 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]